OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients

10Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Hemicrania continua is a strictly unilateral, continuous headache, typically mild to moderate in severity, with severe exacerbations commonly accompanied by cranial autonomic features and migrainous symptoms. It is exquisitely responsive to Indomethacin. However, some patients cannot tolerate treatment, often due to gastrointestinal side effects. Therapeutic alternatives are limited and controlled evidence lacking.

Cite

CITATION STYLE

APA

Miller, S., Correia, F., Lagrata, S., & Matharu, M. S. (2015). OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients. Journal of Headache and Pain, 16(1). https://doi.org/10.1186/s10194-015-0502-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free